Regeneron Pharmaceuticals Inc. (REGN34)
Market Closed
10 Aug, 19:55
B3 B3 Primary R$
68. 53
+1.94
+2.9134%
R$
362.64B Market Cap
24.52 P/E Ratio
0.22% Div Yield
1,556 Volume
42.79 Eps
R$ 66.59
Previous Close Want to track REGN34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
REGN34 Earnings Reports FAQ
What is the earnings per share (EPS) for REGN34?
The current EPS is 42.79.
What is the company's earnings growth rate?
Regeneron Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Regeneron Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Regeneron Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for REGN34 at this time, as Regeneron Pharmaceuticals Inc has no recent EPS data to calculate it.
